SCHEMBL13325440

SCHEMBL13325440

CNC[C@@H]1CCN(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328940 1.00
SCHEMBL90794 1.00
Hydrochloric Acid SCHEMBL31505915 0.98 NCF1 (0.43)
SCHEMBL1488427 0.88 NCF1 (0.52)
SCHEMBL2885366 0.86 CHRM2 (0.38)
SCHEMBL19575592 0.86 CHRM2 (0.38)
SCHEMBL1180350 0.82 L3MBTL1 (0.41)
SCHEMBL10284652 0.82
SCHEMBL19098394 0.81 NCF1 (0.38)
Hydrochloric Acid SCHEMBL4328560 0.80 L3MBTL1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed
US-20210292330-A1 PYRROLIDINE-FUSED HETEROCYCLES ERASCA, INC. 2021-09-23 US disclosed
WO-2018107112-A1 QUINOLONE-BASED COMPOUNDS WITH ANTICANCER ACTIVITY UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2018-06-14 WO disclosed
US-7714019-B2 Indole, azaindole and related heterocyclic pyrrolidine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2010-05-11 US disclosed
US-20090186933-A1 INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC PYRROLIDINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2009-07-23 US disclosed
US-7531552-B2 Indole, azaindole and related heterocyclic pyrrolidine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2009-05-12 US disclosed
US-20080096912-A1 INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC PYRROLIDINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2008-04-24 US disclosed